Detailed Narrative
Smokeable Products Performance
The smokeable products segment delivered strong financial performance with adjusted OCI growth of 6.3% and adjusted OCI margins expanding to 65.1%. This was supported by solid net price realization of 6.3%. Domestic cigarette volumes declined by 2.4% reported, or 4% adjusted for trade inventory, showing moderation in decline. Marlboro strengthened its premium segment share to 59.5%, up 0.1 share point year-over-year, while Basic captured share in the discount segment, contributing to a 0.4 share point increase in total PM USA retail share year-over-year.
on! PLUS National Expansion and Regulatory Efforts
on! PLUS began nationwide shipping in March and is now available in approximately 100,000 stores, covering 85% of nicotine pouch category volume. It is the first product authorized under the FDA's pilot program for streamlining PMTA reviews. Altria has submitted applications for 6 additional on! PLUS varieties across 3 nicotine strengths, believing the science supports authorization within the 180-day statutory timeline.
E-Vapor Category Dynamics and Enforcement
The e-vapor category is showing signs of moderation in illicit flavored disposable product growth, attributed to increased enforcement activity and supply disruption. The estimated number of adult vapers remained stable at 20.5 million, with a modest decline in disposable e-vapor consumers. Altria sees a clear pathway to a compliant legal marketplace through efficient FDA authorization and sustained enforcement.
Macroeconomic Headwinds and Consumer Behavior
Elevated everyday expenses and higher gas prices continue to weigh on discretionary income for price-sensitive adult smokers, driving growth in the discount cigarette segment. While higher-than-normal tax refunds provided some short-term relief, the company is closely monitoring consumer economic conditions. Altria's total portfolio strategy, including Basic and the upcoming Cowboy Cut, aims to manage these trade-down dynamics.
Oral Tobacco Products Segment
The oral tobacco products segment delivered over $400 million in adjusted OCI, with margins at 67.4%, down 1.8 percentage points due to Helix marketing investments and product mix. Total segment reported shipment volume decreased 3.1%, with on! growth offset by lower MST volumes. Adjusted for trade inventory, segment volumes declined approximately 8.5%.
Capital Allocation and Balance Sheet
Altria returned approximately $1.8 billion in dividends and repurchased 4.5 million shares for $280 million in Q1. The company retired over $1 billion of debt, maintaining a strong debt-to-EBITDA ratio of 1.9x, in line with its target.